Evaluation of the ginsburg scheme: where is significant prostate cancer missed?
This paper evaluates Ginsburg Scheme using the robotic platform: Mona Lisa. Using this scheme, significant prostate cancer (sPCa) is missed in fewer men when compared regular biopsies.